Literature DB >> 23712900

The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study.

Lu Liu1, Wei Qi, Daniel K Schwartz, Theodore W Randolph, John F Carpenter.   

Abstract

We investigated the effects of excipients in solutions of keratinocyte growth factor 2 (KGF-2) on protein aggregation during agitation as well as on interfacial shear rheology at the air-water interface. Samples were incubated with or without agitation, and in the presence or absence of the excipients heparin, sucrose, or polysorbate 80 (PS80). The effect of excipients on the extent of protein aggregation was determined by UV-visible spectroscopy and micro-flow imaging. Interfacial shear rheology was used to detect the gelation time and strength of protein gels at the air-water interface. During incubation, protein particles of size ≥1 μm and insoluble aggregates formed faster for KGF-2 solutions subjected to agitation. Addition of either heparin or sucrose promoted protein aggregation during agitation. In contrast, PS80 substantially inhibited agitation-induced KGF-2 aggregation but facilitated protein particulate formation in quiescent solutions. The combination of PS80 and heparin or sucrose completely prevented protein aggregation during both nonagitated and agitated incubations. Interfacial rheological measurements showed that KGF-2 in buffer alone formed an interfacial gel within a few minutes. In the presence of heparin, KGF-2 interfacial gels formed too quickly for gelation time to be determined. KGF-2 formed gels in about 10 min in the presence of sucrose. The presence of PS80 in the formulation inhibited gelation of KGF-2. Furthermore, the interfacial gels formed by the protein in the absence of PS80 were reversible when PS80 was added to the samples after gelation. Therefore, there is a correspondence between formulations that exhibited interfacial gelation and formulations that exhibited agitation-induced aggregation.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  UV-Vis spectroscopy; particle size; physical stability; protein aggregation; protein formulation; rheology; surfactants

Mesh:

Substances:

Year:  2013        PMID: 23712900      PMCID: PMC4174554          DOI: 10.1002/jps.23622

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  31 in total

1.  Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.

Authors:  James G Barnard; Satish Singh; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2010-08-27       Impact factor: 3.534

2.  Stabilization of protein structure by sugars.

Authors:  T Arakawa; S N Timasheff
Journal:  Biochemistry       Date:  1982-12-07       Impact factor: 3.162

3.  Effect of polyanions on the structure and stability of repifermin (keratinocyte growth factor-2).

Authors:  Tiffany Derrick; Adeola O Grillo; Samadhi N Vitharana; Latoya Jones; Jason Rexroad; Ambarish Shah; Melissa Perkins; Thomas M Spitznagel; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2007-04       Impact factor: 3.534

4.  Effect of polyanions on the unfolding of acidic fibroblast growth factor.

Authors:  C J Burke; D B Volkin; H Mach; C R Middaugh
Journal:  Biochemistry       Date:  1993-06-29       Impact factor: 3.162

5.  Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20 degrees C of a recombinant hemoglobin.

Authors:  B A Kerwin; M C Heller; S H Levin; T W Randolph
Journal:  J Pharm Sci       Date:  1998-09       Impact factor: 3.534

6.  Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin.

Authors:  Tim Serno; John F Carpenter; Theodore W Randolph; Gerhard Winter
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

7.  The stabilization of proteins by sucrose.

Authors:  J C Lee; S N Timasheff
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

8.  Effects of pH and polyanions on the thermal stability of fibroblast growth factor 20.

Authors:  Haihong Fan; Samadhi N Vitharana; Tracy Chen; Donald O'Keefe; C Russell Middaugh
Journal:  Mol Pharm       Date:  2007 Mar-Apr       Impact factor: 4.939

9.  Surface activity of a monoclonal antibody.

Authors:  Hanns-Christian Mahler; Frank Senner; Karsten Maeder; Robert Mueller
Journal:  J Pharm Sci       Date:  2009-12       Impact factor: 3.534

10.  Orogenic Displacement of Protein from the Air/Water Interface by Competitive Adsorption.

Authors: 
Journal:  J Colloid Interface Sci       Date:  1999-02-01       Impact factor: 8.128

View more
  11 in total

1.  DEHP Nanodroplets Leached From Polyvinyl Chloride IV Bags Promote Aggregation of IVIG and Activate Complement in Human Serum.

Authors:  Jared R Snell; Connor R Monticello; Cheng Her; Emma L Ross; Ashley A Frazer-Abel; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-06-21       Impact factor: 3.534

Review 2.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

3.  Particle Formation and Aggregation of a Therapeutic Protein in Nanobubble Suspensions.

Authors:  Jared R Snell; Chen Zhou; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2016-07-31       Impact factor: 3.534

4.  Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.

Authors:  Surinder M Singh; Swati Bandi; David N M Jones; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2017-08-24       Impact factor: 3.534

5.  Protein-protein interactions controlling interfacial aggregation of rhIL-1ra are not described by simple colloid models.

Authors:  Lea L Sorret; Madison A DeWinter; Daniel K Schwartz; Theodore W Randolph
Journal:  Protein Sci       Date:  2018-03-03       Impact factor: 6.725

6.  Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.

Authors:  Alana Gerhardt; Aaron C Mcumber; Bao H Nguyen; Rachael Lewus; Daniel K Schwartz; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2015-09-28       Impact factor: 3.534

7.  Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.

Authors:  Adriana-Michelle Wolf Pérez; Nikolai Lorenzen; Michele Vendruscolo; Pietro Sormanni
Journal:  Methods Mol Biol       Date:  2022

8.  Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins.

Authors:  Elena Krayukhina; Kouhei Tsumoto; Susumu Uchiyama; Kiichi Fukui
Journal:  J Pharm Sci       Date:  2014-09-24       Impact factor: 3.534

9.  Parameters Influencing Cavitation Within Vials Subjected to Drop Shock.

Authors:  Rafael Valotta Rodrigues; Meagen Puryear; Donn Sederstrom; Corinne S Lengsfeld
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

10.  Remediating agitation-induced antibody aggregation by eradicating exposed hydrophobic motifs.

Authors:  Rutilio H Clark; Ramil F Latypov; Cyr De Imus; Jane Carter; Zien Wilson; Kathy Manchulenko; Michael E Brown; Randal R Ketchem
Journal:  MAbs       Date:  2014       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.